drugset / Trial / NCT02192567
Open Label Study of DS-5573a
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, sequential dose escalation and expansion study to evaluate the safety, and pharmacokinetics of DS-5573a in Japanese patients with advanced solid malignant tumors.
Timeline
- Start
- 2014-09
- Primary completion
- 2017-01
- Completion
- 2017-01
Outcome
Outcome not reported
Stopped (Business): “Business decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DS-5573a | Unknown | 0.1 mg/kg | Intravenous |
| Subject | DS-5573a | Unknown | 0.3 mg/kg | Intravenous |
| Subject | DS-5573a | Unknown | 1 mg/kg | Intravenous |
| Subject | DS-5573a | Unknown | 3 mg/kg | Intravenous |
| Subject | DS-5573a | Unknown | 10 mg/kg | Intravenous |
| Subject | DS-5573a | Unknown | 20 mg/kg | Intravenous |
| Subject | DS-5573a | Unknown | 30 mg/kg | Intravenous |